(15 days)
Not Found
No
The document describes calibrators for a laboratory assay and does not mention AI or ML in the device description, intended use, or performance studies.
No
This device is a calibrator used for the quantitative determination of vitamin B12 in human serum and plasma, which aids in diagnosis rather than providing direct therapy.
No
The device is a calibrator for a system that determines vitamin B12 levels, not the diagnostic device itself.
No
The device description explicitly states the device is "liquid, ready-for-use materials in a buffered aqueous solution," indicating it is a physical reagent, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for the "quantitative determination of vitamin B12 in human serum and plasma." This is a diagnostic test performed on biological samples in vitro (outside the body).
- Device Description: The device is a "buffered aqueous solution" used for "calibration of the ARCHITECT i System." Calibrators are essential components of many IVD systems, used to ensure the accuracy of the measurements.
- Performance Studies: The document describes a "correlation analysis" performed on "serum specimens tested." This is a typical type of study conducted to validate the performance of an IVD device.
- Predicate Device: The mention of a "Predicate Device(s)" with a K number (K984108) is a strong indicator that this device is being submitted for regulatory clearance as an IVD, often compared to a previously cleared IVD.
All these points align with the definition and characteristics of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Abbott ARCHITECT B12 Calibrators are for the calibration of the ARCHITECT i System when used for the quantitative determination of vitamin B12 in human serum and plasma.
Product codes
JIT
Device Description
The Abbott ARCHITECT B12 Calibrators are liquid, ready-for-use materials in a buffered aqueous solution. Concentrations of the calibrator components span the dynamic range of the assay.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
A correlation analysis was performed between the ARCHITECT B12 6-Point Calibrators and the ARCHITECT 2-Point Calibrators. In this evaluation, serum specimens tested in The ARCHITECT B12 6-point calibration assay, and from 77 to 1988 pg/mL by the ARCHITECT B12 2-point calibration assay. The evaluation yielded the following results:
Regression Method: Least Squares, N: 495, r: 0.998, Slope: 0.96, Intercept: 22
Regression Method: Passing-Bablok, N: 495, r: 0.998, Slope: 0.98, Intercept: 12
Results: In conclusion, these data demonstrate that the performance of the Abbott ARCHITECT In conclusion, intese uata demonstrate and comparable to the performance of the predicate device, when used according to its intended use.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
K 053330
Special 510(k) Summary Abbott ARCHITECT® B12 Calibrators
Summary of Safety and Effectiveness Information Supporting a Substantially Equivalent Determination
According to the requirements of 21 CFR §807.92, the following information provides of According to the requirements of DF OFF 30 for a determination of substantial equivalence.
| Submitter's Name and Address: | Abbott Laboratories
Diagnostics Division
100 Abbott Park Road
Abbott Park, IL 60064
Telephone: (847) 937-4106
Fax: (847) 937-9616
Contact: Margaret.Prochniak@abbott.com |
| ------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|---|
Date Prepared: 29 November 2005
| Device Proprietary Name:
Device Common Name:
Classification Number: | Abbott ARCHITECT® B12 Calibrators
Vitamin B12
Clinical Chemistry, 21 CFR §862.1150 |
|---------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Predicate Device: | Abbott ARCHITECT® B12
510(k) Number: K984108
Concurrence Date: 3 February 1999 |
| Device Description: | The Abbott ARCHITECT B12 Calibrators are
liquid, ready-for-use materials in a buffered
aqueous solution. Concentrations of the calibrator
components span the dynamic range of the assay. |
| Intended Use: | The Abbott ARCHITECT B12 Calibrators are for
the calibration of the ARCHITECT i System when
used for the quantitative determination of vitamin
B12 in human serum and plasma. |
1
A correlation analysis was performed between the ARCHITECT B12 6-Point Calibrators and the ARCHITECT 2-Point Calibrators. In this evaluation, serum specimens tested and the ARCHITECT 2-1 only Callorations in The ARCHITECT B12 6-point calibration assay, and from 77 to 1988 pg/mL by the ARCHITECT B12 2-point calibration assay. The evaluation yielded the following results:
| Regression Method | N | r | Slope | Intercept |
|---|---|---|---|---|
| Least Squares | 495 | 0.998 | 0.96 | 22 |
| Passing-Bablok | 495 | 0.998 | 0.98 | 12 |
n = number of specimens
r = correlation coefficient
In conclusion, these data demonstrate that the performance of the Abbott ARCHITECT In conclusion, intese uata demonstrate and comparable to the performance of the predicate device, when used according to its intended use.
Prepared and Submitted 29 November 2005 by:
Margaret Bochniak 11/29/05
Margaret Prochniak, M.S. Senior Regulatory Affairs Specialist ADD Regulatory Affairs Phone: (847) 937-4106 Fax: (847) 937-9616 E-mail: Margaret Prochniak@abbott.com
Abbott Laboratories Diagnostics Division Department 9VA, Building AP6C-2 100 Abbott Park Road Abbott Park, IL 60064-6095
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a stylized eagle with three stripes representing the feathers. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the eagle.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
DEC 16 2005
Ms. Margaret Prochniak, M.S. Sr. Regulatory Affairs Specialist Abbott Laboratories Diagnostics Division Dept. 9VA, Bldg. AP 6C-2 100 Abbott Park Road Abbott Park, IL 60064-6095
Re: K053330
Trade/Device Name: Abbott ARCHITECT® B12 Calibrators Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIT Dated: November 29, 2005 Received: December 1, 2005
Dear Ms. Prochniak:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
3
Page 2 --
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Alberto Guti
Alberto Gutierrez, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K 053330
Device Name: Abbott ARCHITECT® B12 Calibrators
Indications For Use:
The Abbott ARCHITECT B12 Calibrators are for the calibration of the The Abbott ARCHITECT BT2 Canbrators are for the canoration of vitamin B12 in human serum and plasma.
Prescription Use _ X (Part 21 CFR 801 Subpart D) OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(Please Do Not Write Below This Line. Continue on Another Page If Needed)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol C. Benson
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K053330